Skip to main content
PolicySpeak
← All legislative files
2025/0384(COD)COM(2025)747INTA

Monitoring and controlling drug precursors

Monitoring and controlling drug precursors and repealing Regulations (EC) No 273/2004 and (EC) No 111/2005

Stage
Committee report adopted, reached 20 May 2026
Procedure
OLP · Ordinary legislative procedure
Rapporteurs
Nicolas Bay (ECR), Bartłomiej Sienkiewicz (EPP)
Lead DG
DG TAXUD
Commissioner
Maroš Šefčovič
Last activity
23 Jun 2026
Legal basis
TFEU Art. 114; TFEU Art. 207; TFEU Art. 294; TFEU Art. 33
11 entries · record as of 14 Sept 2026

Where it stands

Latest: Committee amendments tabled, 23 Jun 2026.

  1. 7 Jun 2023
    • Call for evidence closed: Revision of the EU drug precursors legislation, 14 responses · Commission
  2. 10 Jul 2024
    • Public consultation closed: Revision of the EU drug precursors legislation, 57 responses · Commission
  3. 4 Dec 2025
    • Adoption of legislative proposal by the Commission
  4. 13 Jan 2026
    • Decision on procedure
  5. 12 Feb 2026
    • Referral of the legislative proposal to the EP committee responsible (announced in plenary) · Parliament
    • Referred to committee
  6. 7 Apr 2026
    • Feedback on adopted proposal closed: Revision of the EU drug precursors legislation, 7 responses · Commission
  7. 20 May 2026
    • Committee report tabled
    • EP committee draft report · Parliament committee
  8. 23 Jun 2026
    • Committee amendments tabled
    • Tabling of amendments in the EP committee responsible · Parliament committee
12 people

Who is on it

The Parliament's rapporteurs, shadow rapporteurs and opinion rapporteurs currently on this file.

RoleNameGroupCountryCommittee
Co-rapporteurNicolas BayECRFRINTA
Co-rapporteurBartłomiej SienkiewiczEPPPLLIBE
Shadow rapporteurBenoit CassartRenewBE
Shadow rapporteurBrando BenifeiS&DIT
Shadow rapporteurEvin IncirS&DSE
Shadow rapporteurGiuseppe AntociThe LeftIT
Shadow rapporteurJaroslav BžochPfECZ
Shadow rapporteurLynn BoylanThe LeftIE
Shadow rapporteurMika AaltolaEPPFI
Shadow rapporteurPaolo InselviniECRIT
Shadow rapporteurSaskia BricmontGreens/EFABE
Shadow rapporteurSophie WilmèsRenewBE
4 documents

Documents

Newest first. Each opens at its source.

1 consultation

Consultations on it

The Commission's Have Your Say consultations linked to this file. Where we publish the positions filed, the title opens them here.

ConsultationFeedback deadlineFeedback received
7 Apr 202678

Summary

Generated

This regulation strengthens monitoring and control of drug precursors to prevent diversion into illicit markets, repealing outdated Regulations (EC) No 273/2004 and 111/2005. It updates administrative cooperation, export controls, and labeling requirements to enhance public health and internal market functioning. Affects chemical traders, customs authorities, and EU member states.

What the workspace adds on this file

Everything above is the public record. Subscribers see this page with their own layer on top.

Why it matters to you

What this file means for your organization, assessed against your own priorities.

What moved

When this file moves, it reaches your own briefing, with a link to its source.

Your contacts on it

Your team's contacts logged against this file: who you met, what was said and the next step.

A first draft

A statement, a member update or a meeting brief on this file, in your organization's voice, with its sources.

Sources: EP Legislative Observatory · EU Law Tracker. Record as of 14 Sept 2026. Something wrong on this page? Report an error.

Request access

See this file with your own layer on top: why it matters to you, your contacts on it and a first draft. We’ll schedule a 20-minute walkthrough.

EU-hosted · GDPR-compliant · Trust Center →

By submitting, you agree to our privacy policy.